On the contrary, B cell specific double transgenic mice overexpressing anti-apoptotic Bcl-2 and dominant negative form Traf2 adapter develop CLL/SLL-like phenotype with restricted IGHV usage mimicking CLL BCR stereotypes (59). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.